Search

Your search keyword '"Kamouchi, Masahiro"' showing total 586 results

Search Constraints

Start Over You searched for: Author "Kamouchi, Masahiro" Remove constraint Author: "Kamouchi, Masahiro"
586 results on '"Kamouchi, Masahiro"'

Search Results

3. Stroke genetics informs drug discovery and risk prediction across ancestries

5. Decreased Estimated Glomerular Filtration Rate and Proteinuria and Long-Term Outcomes After Ischemic Stroke: A Longitudinal Observational Cohort Study

6. Multi‐phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations

8. Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan

10. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries

14. The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation

19. Association between abdominal adiposity and clinical outcomes in patients with acute ischemic stroke.

20. Body temperature in the acute phase and clinical outcomes after acute ischemic stroke.

21. Comparison of Prasugrel and Clopidogrel in Thrombotic Stroke Patients with Risk Factors for Ischemic Stroke Recurrence: An Integrated Analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-III.

24. Predictive performance of machine learning-based models for post-stroke clinical outcomes in comparison with conventional prognostic scores: a multicenter hospital-based observational study (Preprint)

26. Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study

27. Sex Differences in Long-Term Functional Decline after Ischemic Stroke: A Longitudinal Observational Study from the Fukuoka Stroke Registry.

28. Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study

29. Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)

33. Association Between Onset-to-Door Time and Clinical Outcomes After Ischemic Stroke

34. Association between decreases in serum uric acid levels and unfavorable outcomes after ischemic stroke: A multicenter hospital-based observational study.

39. Stroke genetics informs drug discovery and risk prediction across ancestries

40. Day-by-Day Blood Pressure Variability in the Subacute Stage of Ischemic Stroke and Long-Term Recurrence

43. β-Cell Function and Clinical Outcome in Nondiabetic Patients With Acute Ischemic Stroke

44. Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)

45. Day-by-Day Blood Pressure Variability and Functional Outcome After Acute Ischemic Stroke: Fukuoka Stroke Registry

46. Sex Differences in Short-Term Outcomes After Acute Ischemic Stroke: The Fukuoka Stroke Registry

Catalog

Books, media, physical & digital resources